Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methylglyoxal-scavenging cyclic peptides and their use for the prevention and treatment of diseases associated with elevated methylglyoxal levels

Methylglyoxal-scavenging cyclic peptides and their use for the prevention and treatment of diseases associated with elevated methylglyoxal levels

US Patent 11202833 · Granted Dec 21, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of labeled inhibitors of prostate specific membrane antigen (PSMA), as agent2024
Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for th2024
Cyclic NTCP-targeting peptides and their uses as entry inhibitors2022
Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for th2021
Liposomal formulation for the oral hepatic delivery of drugs2020
CD44v6-derived cyclic peptides for treating cancers and angiogenesis related dis2020
Liposomes containing cell penetrating peptides and tetraetherlipids for the oral2020
Hydrophobic modified peptides and their use for liver specific targeting2019
Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as im2019
Conjugates for protection from nephrotoxic active substances2019
Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as im2019
Hydrophobic modified peptides for liver specific diagnosis2019